| Sep 11 |
Xencor Announces Pricing of $175 Million Public Offering of Common Stock
|
| Sep 10 |
Xencor announces public offering of common stock
|
| Sep 10 |
Xencor Announces Proposed Public Offering of Common Stock
|
| Sep 10 |
Xencor Stock Gains 23% on Encouraging Pipeline Advancements
|
| Sep 9 |
Xencor stock rallies 24% amid drug development updates
|
| Sep 9 |
Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
|
| Sep 6 |
Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024
|
| Aug 7 |
Estimating The Intrinsic Value Of Xencor, Inc. (NASDAQ:XNCR)
|
| Aug 5 |
Xencor Non-GAAP EPS of -$1.07 misses by $0.28, revenue of $17M misses by $2.81M
|
| Aug 5 |
Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates
|
